Review Article
Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis
Table 1
Characteristics of included studies.
| S. no. | Author | Sample size | Population studied | Study design | Duration of follow-up | Test group | Control group |
| (1) | Bharani et al., 2002 [14] | 58 | Male with stable angina (NYHA class II-III) | Randomized crossover placebo controlled trial | 4 weeks | Terminalia arjuna (500 mg TDS) | Isosorbide mononitrate (20 mg BD)
|
| (2) |
Kumar et al., 1999 [13]
| 20 | Adult with stable angina | Open comparative trial | 12 weeks | Hartone 2 cap BD for 6 months, 1 cap BD for next 6 months | Isosorbide mononitrate (20 mg BD) |
| (3) |
Dwivedi and Jauhari, 1997 [15]
| 24 | Adult with stable angina (NYHA-IV) | Randomised controlled trial | 12 weeks | Conventional + Terminalia arjuna | Conventional |
| (4) |
Dwivedi and Agarwal, 1994 [16]
| 20 | Adult with stable and unstable angina | Before and after treatment comparison | 12 weeks | 500 mg Terminalia arjuna BD
| — |
| (5) |
Jain et al., 1992 [17]
| 25 | Adult with stable angina | Before and after treatment comparison | 12 weeks | Conventional + Terminalia arjuna 500 mg BD | — |
|
|